Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

In the media

RPS opposes Saatchi Bill

6 March 2015: Royal Pharmaceutical Society president Ash Soni was a signatory to a letter published in The Times protesting against the Saatchi Bill. The letter stated: “What patients need is continued support for scientifically based medical research, but what they would get under this Bill is the pretence that medical innovation sanctioned by it could cure fatal illness, when in fact it could undermine long established principles of patient safety.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068077

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.